Digestive cancer registry study
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study collects information from patients with different types of digestive cancers to better understand these diseases and improve future care. It does not test a new treatment, but helps doctors learn more about digestive cancers over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have a diagnosis of one of these cancers: esophageal, stomach, pancreatic, liver, gallbladder or bile duct, small intestine, appendix, gastrointestinal stromal tumor (GIST), colorectal, anal canal, or a hereditary digestive cancer
- You must be willing to give written permission to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects medical information from people with gastrointestinal (GI) cancer, both those treated in the past and those currently receiving care. The goal is to learn more about the disease and improve future treatments.
This trial collects health information and samples (a “cancer repository”) to help researchers study cancer and cancer risk. You may be able to join if you’ve had cancer before or if you’re at higher risk or have concerning findings.
This study collects information from people diagnosed with pancreatic cancer. It aims to improve care by learning from your medical records.
This study collects information and blood samples from people with gallbladder cancer to build a database. It helps researchers learn more about the disease and may lead to better treatments in the future.
This registry collects information from people with liver cancer or bile duct cancer to learn more about the disease and its treatment. Anyone 18 or older with any stage of these cancers can join.
This study builds a database of people with colorectal cancer. It may help doctors learn from real-world information to improve future care.
Hear when a new Bile Duct Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.